Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s002800050905PMID 10071987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.

  1997influential reference
• Effect of suramin on human esophageal cancer cells in vitro and in vivo.

  1997cited by this paper
• Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies.

  1997cited by this paper
• Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells

  1997cited by this paper
• Suramin Induces Phosphorylation of the High‐Affinity Nerve Growth Factor Receptor in PC12 Cells and Dorsal Root Ganglion Neurons

  1996influential reference
• Differential Regulation of Fibroblast Growth Factor (FGF) Receptor-1 mRNA and Protein by Two Molecular Forms of Basic FGF

  1996cited by this paper
• Antiproliferative and angiostatic activity of suramin analogues.

  1995cited by this paper
• Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.

  1995cited by this paper
• Effects of suramin on human lung cancer cell lines.

  1995cited by this paper
• Cell-specific Purinergic Receptors Coupled to Ca2+ Entry and Ca2+ Release from Internal Stores in Adrenal Chromaffin Cells

  1995cited by this paper
• Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.

  1994cited by this paper
• Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC‐3

  1993cited by this paper
• Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells.

  1993cited by this paper
• In vitro effect of suramin on lung tumour cells.

  1993cited by this paper
• Suramin inhibits the phosphorylation and catalytic activity of DNA topoisomerase II in human lung cancer cells.

  1993cited by this paper
• Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.

  1993cited by this paper
• Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.

  1992cited by this paper
• Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.

  1992cited by this paper
• Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex.

  1992cited by this paper
• Pleiotropic actions of suramin on the proliferation of human breast‐cancer cells in vitro

  1992cited by this paper
• Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.

  1992influential reference
• Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.

  1992cited by this paper
• Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy.

  1992cited by this paper
• Nature of the interaction of growth factors with suramin.

  1992cited by this paper
• Suramin inhibits growth of human osteosarcoma xenografts in nude mice.

  1991cited by this paper
• Epidermal growth factor receptor expression and suramin cytotoxicity in vitro.

  1990cited by this paper
• Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells.

  1990cited by this paper
• Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.

  1990cited by this paper
• Antiproliferative effects of suramin on androgen responsive tumour cells.

  1990cited by this paper
• Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.

  1989cited by this paper
• Suramin: an anticancer drug with a unique mechanism of action.

  1989cited by this paper
• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

  1989cited by this paper
• Circulating glycosaminoglycan anticoagulants associated with suramin treatment.

  1988cited by this paper
• Circulating glycosaminoglycan anticoagulants associated with suramin treatment.

  1988cited by this paper

• Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein

  2021cites this paper
• Endothelial calcium dynamics, connexin channels and blood-brain barrier function.

  2013cites this paper
• P2X(7) receptor antagonists display agonist-like effects on cell signaling proteins.

  2011cites this paper
• Characterizing cytokine transport in hemoadsorption beads used to treat sepsis

  2011cites this paper
• Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.

  2008cites this paper
• Suramin Promotes Proliferation and Scattering of Renal Epithelial Cells

  2005influential citation
• Cancer Biology and Hormesis: Human Tumor Cell Lines Commonly Display Hormetic (Biphasic) Dose Responses

  2005cites this paper
• Stimulation of Extracellular Signal-Regulated Kinase Pathway by Suramin with Concomitant Activation of DNA Synthesis in Cultured Cells

  2004cites this paper
• Suramin Sensitizes Cells to Ionizing Radiation by Inactivating DNA-Dependent Protein Kinase

  2004cites this paper
• Suramin sensitizing cells to ionizing radiation by inactivating DNA-dependent protein kinase.

  2004cites this paper
• Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.

  2004cites this paper
• Adhesion or Plasmin Regulates Tyrosine Phosphorylation of a Novel Membrane Glycoprotein p80/gp140/CUB Domain-containing Protein 1 in Epithelia*

  2004cites this paper
• Suramin prevents cerebellar granule cell-death induced by dequalinium.

  2001cites this paper
• Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO).

  1999cites this paper